Answers are grounded in this paper and cite their sources.
Background Systemic inflammation and metabolic dysfunction may influence musculoskeletal healing, but their combined relationship with recovery after meniscal repair is uncertain. We examined whether data-derived inflammatory–metabolic clusters were associated with postoperative outcomes. Methods This retrospective single-centre cohort included 619 patients who underwent arthroscopic meniscal repair between January 2018 and June 2021; outcome ascertainment continued through June 2026. K-means clustering used nine standardized preoperative inflammatory and metabolic variables. The primary outcome was the 6-month Lysholm score. Secondary outcomes included recovery trajectory, achievement of a 9-point minimal clinically important difference (MCID), pain improvement, and revision-free survival. Main models adjusted for demographic and clinical covariates, with additional sensitivity adjustment for meniscal and surgical characteristics. Results Three clusters were identified: low inflammatory/normal metabolic ( n = 276, 44.6%), moderate inflammatory/normal metabolic ( n = 275, 44.4%), and high inflammatory–metabolic ( n = 68, 11.0%). The high inflammatory–metabolic cluster had a high prevalence of diabetes and markedly elevated hs-CRP, glucose, and HbA1c. At 6 months, its adjusted Lysholm score was statistically lower than that of the low inflammatory/normal metabolic cluster (adjusted mean difference, − 4.05 points; 95% CI, − 5.92 to − 2.18; P < 0.001), although this difference was smaller than the prespecified 9-point MCID. MCID achievement was less frequent (adjusted OR, 0.204; 95% CI, 0.057–0.759), but rates were high in all groups. The high inflammatory–metabolic cluster was also associated with revision surgery (adjusted HR, 2.47; 95% CI, 1.43–4.28). Conclusions In this predominantly older, selected cohort, a high inflammatory–metabolic cluster was associated with statistically poorer functional recovery and a higher revision risk. The average 6-month functional difference was below the prespecified MCID, and residual confounding and lack of external validation limit clinical application. These findings should be considered hypothesis-generating. Clinical trial number Not applicable.
No takes yet. Share an insight, caveat, or question.
Fan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: